Hizentra patient Appolos talks through his experiences with CIDP, treatment, and benefits of Hizentra and Hizentra support services.
WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.
If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.
See your doctor for a full explanation, and the full prescribing information for complete boxed warning.
Join us for a free educational program for CIDP patients and their caregivers! These programs feature a presentation from a trained nurse who treats CIDP and stories from a CIDP patient just like you.
Webinar Series: Take part in our live webinar series at 8 PM ET, where you can ask questions and join in the discussion from the convenience of your home. Register for an online event: https://www.hizentrapatientprogram.com/
Please see full Important Safety Information at the end of this video, and view the full Prescribing Information here: http://bit.ly/HIZ_PI
Please subscribe to the Hizentra YouTube channel here: https://bit.ly/3ecGE5C
View the Hizentra PI Facebook page here: https://www.facebook.com/HizentraPI/
View the Hizentra CIDP Facebook page here: https://www.facebook.com/hizentracidp/